- Home
- GLMD vs FRSX Comparison
GLMD vs FRSX Comparison
Compare GLMD & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- FRSX
- Stock Information
- Founded
- GLMD 2000
- FRSX N/A
- Country
- GLMD Israel
- FRSX Israel
- Employees
- GLMD N/A
- FRSX N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- FRSX Computer Software: Prepackaged Software
- Sector
- GLMD Health Care
- FRSX Technology
- Exchange
- GLMD Nasdaq
- FRSX Nasdaq
- Market Cap
- GLMD 7.5M
- FRSX 8.2M
- IPO Year
- GLMD 2014
- FRSX 2017
- Fundamental
- Price
- GLMD $1.48
- FRSX $2.09
- Analyst Decision
- GLMD Hold
- FRSX
- Analyst Count
- GLMD 1
- FRSX 0
- Target Price
- GLMD N/A
- FRSX N/A
- AVG Volume (30 Days)
- GLMD 213.6K
- FRSX 73.7K
- Earning Date
- GLMD 11-13-2025
- FRSX 09-21-2025
- Dividend Yield
- GLMD N/A
- FRSX N/A
- EPS Growth
- GLMD N/A
- FRSX N/A
- EPS
- GLMD N/A
- FRSX N/A
- Revenue
- GLMD N/A
- FRSX $452,000.00
- Revenue This Year
- GLMD N/A
- FRSX N/A
- Revenue Next Year
- GLMD N/A
- FRSX N/A
- P/E Ratio
- GLMD N/A
- FRSX N/A
- Revenue Growth
- GLMD N/A
- FRSX N/A
- 52 Week Low
- GLMD $1.15
- FRSX $1.98
- 52 Week High
- GLMD $23.80
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- GLMD 51.13
- FRSX 47.59
- Support Level
- GLMD $1.33
- FRSX N/A
- Resistance Level
- GLMD $1.60
- FRSX $2.63
- Average True Range (ATR)
- GLMD 0.10
- FRSX 0.15
- MACD
- GLMD 0.03
- FRSX -0.08
- Stochastic Oscillator
- GLMD 66.67
- FRSX 79.47
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.